Supporting information for Lee et al. (2002) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.232308999
Table 2. List of selected genes altered in the expression by aging
Identifier | FC, age | %CR effect | Gene | P value | pp |
Glucose/carbohydrate/energy metabolism | |||||
X04591* | 1.7 | 86 | Creatine kinase, brain (Ckb) | 0.0016 | 0.81 |
AW210370 | 1.6 | 8 | Homologous to human glucan (1,4-alpha-), branching enzyme 1 | 0.0427 | 0.64 |
J03928* | 1.5 | 105 | Phosphofructokinase, liver, B-type (Pfk1) | 0.0005 | 0.85 |
AJ001418* | -8.5 | 139 | Pyruvate dehydrogenase kinase 4 (Pdk4) | 0.0020 | 0.80 |
D42083* | -5.0 | 22 | Fructose 1,6-bisphosphatase 2 (Fbp2) | 0.0013 | 0.82 |
AB010742* | -2.6 | 146 | Uncoupling protein 3, mitochondrial (Ucp3) | 0.0038 | 0.77 |
Fatty acid metabolism Fatty acid transport into cytosol and mitochondrial matrix | |||||
U15976 | -2.0 | 25 | Solute carrier family 27 (fatty acid transporter), member 1 (Slc27a1) | 0.0055 | 0.76 |
L23108 | -1.8 | -14 | CD36 antigen (Cd36) | 0.0363 | 0.65 |
AF017175* | -3.3 | 46 | Carnitine O-palmitoyl transferase I, mitochondrial liver isoform | 0.0004 | 0.86 |
X85983 | -1.6 | -15 | Carnitine acetyltransferase (Crat) | 0.0211 | 0.68 |
AB017112* | -1.5 | 73 | Mitochondrial carnitine/acylcarnitine translocase (Slc25a20) | 0.0011 | 0.82 |
Mitochondrial b -oxidation | |||||
Y14004* | -5.1 | 71 | Acyl-CoA thioesterase 1, cytosolic (Cte1) | 0.0007 | 0.84 |
U69543* | -4.6 | 89 | Lipase, hormone sensitive (Lipe) | 0.0073 | 0.74 |
AF006688* | -1.8 | 38 | Acyl-Coenzyme A oxidase 1, palmitoyl (Acox1) | 0.0213 | 0.68 |
AW226939* | -1.6 | 182 | Carboxylesterase 3 (Ces3) | 0.0154 | 0.70 |
AI840013* | -1.6 | 174 | Peroxisomal delta3, delta2-enoyl-coenzyme A isomerase (Peci) | 0.0054 | 0.76 |
AF030343 | -1.5 | 13 | Enoyl coenzyme A hydratase 1, peroxisomal (Ech1) | 0.0486 | 0.63 |
Z14050 | -1.5 | 26 | Dodecenoyl-coenzyme A delta isomerase (Dci) | 0.0164 | 0.70 |
U89906 | 4.5 | 32 | Alhpa-methylacyl-CoA racemase (Amacr) | 0.0103 | 0.72 |
Neurodegeneration | |||||
D29678* | 6.3 | 74 | Cyclin-dependent kinase 5 (Cdk5) | 0.0051 | 0.76 |
AF044672 | 6.0 | -80 | Synuclein, alpha (Snca) | 0.0046 | 0.76 |
Protein synthesis, modification, and turnover | |||||
AJ006584 | -2.2 | -10 | Eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked (Eif2s3y) | 0.0030 | 0.78 |
U28656 | -1.7 | 19 | Eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1)/PHAS-I | 0.0002 | 0.88 |
AW121930 | -1.6 | 10 | Homologous to human eIF4B | 0.0122 | 0.71 |
AB007139 | 2.7 | 129 | Proteasome (prosome, macropain) 28 subunit, 3 (Psme3) | 0.0262 | 0.67 |
M74227 | 2.4 | 7 | Peptidylprolyl isomerase C (Ppic) | 0.0062 | 0.75 |
AW050342* | 1.6 | 210 | Ubiquitin specific protease 23 (Usp23) | 0.0085 | 0.73 |
AB024303* | 1.5 | 115 | Ubiquitin-like 1 (sentrin) activating enzyme E1A (Uble1a) | 0.0334 | 0.65 |
Extracellular matrix proteins | |||||
AF011450* | 3.4 | 134 | Procollagen, type XV (Col15a1) | 0.0285 | 0.66 |
X57337 | 2.1 | 60 | Procollagen C-proteinase enhancer protein (Pcolce) | 0.0315 | 0.66 |
AF064749* | 2.1 | 189 | Type VI collagen alpha 3 subunit | 0.0134 | 0.71 |
M15832* | 1.9 | 59 | Collagen alpha 1 (IV) | 0.0007 | 0.84 |
D82964 | 1.7 | 0 | Hyaluronan synthase 1 (Has1) | 0.0388 | 0.64 |
X60676* | 1.5 | 231 | Serine (or cysteine) proteinase inhibitor, clade H, member 1 (Serpinh1) | 0.0048 | 0.76 |
Structure, structural modulation, cellcell interaction, and muscle contraction | |||||
AJ010305 | 15.2 | 81 | Smoothelin (Smtn) | 0.0275 | 0.67 |
U82758* | 8.1 | 71 | Claudin-5 | 0.0069 | 0.74 |
L48687* | 5.9 | 77 | Sodium channel, voltage-gated, type I, beta polypeptide (Scn1b) | 0.0064 | 0.75 |
AJ011740 | 4.2 | 23 | Smarcb1 | 0.0405 | 0.64 |
X13297 | 2.2 | 28 | Actin, alpha 2, smooth muscle, aorta (Acta2) | 0.0230 | 0.68 |
X69902* | 1.9 | 93 | Integrin alpha 6 (Itga6) | 0.0033 | 0.78 |
AF035263 | 1.7 | 38 | Smarce1 | 0.0209 | 0.68 |
M63801* | 1.6 | 159 | Gap junction membrane channel protein alpha 1 (Gja1) (Connexin 43) | 0.0073 | 0.74 |
X65493* | 1.6 | 162 | Intercellular adhesion molecule 2 (Icam2) | 0.0273 | 0.67 |
AJ131711 | 1.6 | 21 | Troponin T1, skeletal, slow (Tnnt1) | 0.0005 | 0.85 |
Z19543 | 1.6 | 67 | Calponin 2 (Cnn2) | 0.0223 | 0.68 |
X69064 | 1.5 | 63 | Ankyrin 1, erythroid (Ank1) | 0.0338 | 0.65 |
AJ000328 | -3.3 | 14 | Type 2 desmoglein | 0.0086 | 0.73 |
Y08027* | -1.6 | 167 | NAD (P)+ arginine ADP-ribosyltransferase | 0.0209 | 0.68 |
M91236 | -1.6 | 12 | Gap junction membrane channel protein beta 5 (Gjb5) (Connexin 31.1) | 0.0131 | 0.71 |
AJ010045 | -1.6 | 28 | Neuroepithelial cell transforming gene 1 (Net1) | 0.0018 | 0.81 |
AW121185 | -1.5 | 39 | Dynein, cytoplasmic, heavy chain 1 (Dnchc1) | 0.0069 | 0.74 |
This table lists the genes, of selected classes, that were significantly (P value < 0.05) altered in expression and displayed a fold change greater than 1.5 when comparing 30-month-old control mice with 5-month-old control mice. The last two columns display P values computed by the bootstrap method and their posterior probabilities (pp). %CR effect was computed by ((O CR)/(O Y)) ´ 100, where O, CR, and Y are average intensities of 30-month-old control, 30-month-old CR, and 5-month-old control groups, respectively. We note that alterations in gene expression with aging may be associated with alterations in cell populations in the heart.
*Significantly different between CR and control animals.